Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017

WASHINGTON, April 13, 2017 /PRNewswire/ -- Conference Call and Webcast to Follow

Vanda Pharmaceuticals Inc. (Vanda) VNDA today announced it will release results for the first quarter of 2017 on Tuesday, May 2, 2017, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Tuesday, May 2, 2017, during which management will discuss the first quarter 2017 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4539 (domestic) or 1-847-619-6396 (international) and use passcode 44748467.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, May 2, 2017, beginning at 7:00 PM ET and will be accessible until Tuesday, May 9, 2017, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 44748467.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2017-financial-results-on-may-2-2017-300439682.html

SOURCE Vanda Pharmaceuticals Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!